Latest news

The packaging of ophthalmic medicines plays a crucial role in the safety and efficacy of eye treatments. From sterility solutions to sustainable materials and new preservative-free dosing systems, innovations aim to improve the patient experience and reduce environmental impact. Discover the latest challenges and trends in the industry, where technology and sustainability merge to ensure safer and more accessible eye care.

Bormioli Pharma today announced a partnership with Chiesi, an international, research-focused biopharmaceutical company (Chiesi Group), to supply Carbon Capture PET bottles. These will be used to package a medication indicated for the prophylaxis and treatment of seasonal and perennial allergic rhinitis, as well as vasomotor rhinitis.

From 8th to 10th October in Milan (Fiera Milano, booth 20A2), the company will showcase EcoPositive, one of the widest pharma-grade low impact product ranges available on the market, featuring over 3,000 items.

Asamedic, a pioneer in emergency medical treatment of myocardial infarction, and Bormioli Pharma announce their partnership for the commercialization of Coxor™ 300mg Acetylsalicylic acid, revolutionary life-saving medication designed for emergency treatment of suspected acute myocardial infarction.

Dual chamber packaging is an innovation in oral drug reconstitution, offering a safe, precise and user-friendly solution. Learn how this technology improves active ingredient stability and reduces dosing errors, overcoming the limitations of traditional solutions. Read the full article to find out more about the advantages and latest developments in this field.

This important recognition places the leading pharma packaging manufacturer in the top 5% of all evaluated companies, showing improved performances on environmental safeguarding, workplace practices and corporate ethics.